APA (7th ed.) Citation

F, M., AL, F., C, B., G, G., L, B., P, C., . . . S, S. (2017). Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma. European journal of medicinal chemistry, 127, 369. https://doi.org/10.1016/j.ejmech.2016.12.036

Chicago Style (17th ed.) Citation

F, Musumeci, et al. "Identification of New Pyrrolo[2,3-d]pyrimidines as Src Tyrosine Kinase Inhibitors In vitro Active Against Glioblastoma." European Journal of Medicinal Chemistry 127 (2017): 369. https://doi.org/10.1016/j.ejmech.2016.12.036.

MLA (9th ed.) Citation

F, Musumeci, et al. "Identification of New Pyrrolo[2,3-d]pyrimidines as Src Tyrosine Kinase Inhibitors In vitro Active Against Glioblastoma." European Journal of Medicinal Chemistry, vol. 127, 2017, p. 369, https://doi.org/10.1016/j.ejmech.2016.12.036.